Marinus Pharmaceuticals Stock News

Marinus Pharmaceuticals has pivoted from postpartum depression to focus on seizure disorders, leading to FDA approval for Ztalmy (ganaxolone) for treating Cyclin-dependent Kinase-like 5 Deficiency Dis

Marinus Pharmaceuticals (MRNS) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $0.52 per share a year ago.

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced

Marinus Pharmaceuticals (MRNS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in th

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS ) Q4 2022 Earnings Conference Call March 7, 2023 4:30 PM ET Company Participants Sasha Damouni Ellis - Vice President of Corporate Affairs and Investor Relat

Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 16.48% and 46.22%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the st

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced

RBC Capital Markets initiated coverage on Marinus Pharmaceuticals Inc (NASDAQ: MRNS) with an Outperform rating, Speculative Risk, and a price target of $23, equivalent to an upside of almost 300%.

Upgrades For Par Pacific Holdings Inc (NYSE:PARR), Piper Sandler upgraded the previous rating of Neutral to Overweight. In the third quarter, Par Pacific Hldgs showed an EPS of $2.88, compared to $0.7

More penny stocks with unusual options activity right now. The post 10 Hot Penny Stocks With Unusual Options Activity, Time To Buy?

More penny stocks with unusual options activity right now. The post 7 Hot Penny Stocks With Unusual Options Activity, Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information |

More penny stocks with unusual options activity right now. The post 7 Hot Penny Stocks With Unusual Options Activity, Time To Buy?

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. TaskUs, Inc. (NAS

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast ca